Publicaciones en las que colabora con José Ignacio Lorenzo González (19)

2021

  1. Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

    European Journal of Haematology, Vol. 106, Núm. 1, pp. 114-125

2019

  1. Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation

    European Journal of Haematology, Vol. 103, Núm. 3, pp. 172-177

  2. Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen

    European Journal of Haematology, Vol. 102, Núm. 4, pp. 331-340

2018

  1. Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation

    Annals of Hematology, Vol. 97, Núm. 1, pp. 161-167

2017

  1. ABO incompatibility does not influence transfusion requirements in patients undergoing single-unit umbilical cord blood transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 394-399

2004

  1. Basal CD34+ cell count predicts peripheral blood progenitor cell mobilisation and collection in healthy donors after administration of granulocyte colony-stimulating factor

    Haematologica, Vol. 89, Núm. 12, pp. 1530-1532

2001

  1. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII

    British Journal of Haematology, Vol. 114, Núm. 1, pp. 174-176

1989

  1. Validation of survival‐predictive models in myelodysplastic syndromes

    American Journal of Hematology

1988

  1. Acute microgranular promyelocytic leukaemia (M3 variant). Study of 14 patients

    Sangre, Vol. 33, Núm. 2, pp. 102-107

  2. Comparative analysis of three therapeutic regimes for remission induction in acute myeloblastic leukaemia based on the combination of anthracycline and cytosine arabinoside

    Sangre, Vol. 33, Núm. 6, pp. 497-504

  3. Factores pronósticos en los síndromes mielodisplásicos. Validación de modelos predictivos de supervivencia obtenidos mediante análisis multivariante.

    Sangre, Vol. 33, Núm. 2, pp. 121-126

  4. Paroxysmal noctural hemoglobinuria (PNH). Biological and clinical features of 17 cases

    Anales de Medicina Interna, Vol. 5, Núm. 4, pp. 173-178

  5. Prognostic factors and predictive models of the different causes of failure of the induction of remission in acute non-lymphoblastic leukemia

    Medicina Clinica, Vol. 90, Núm. 4, pp. 151-155

  6. Prognostic factors in chronic myelodysplastic syndromes: A multivariate analysis in 107 cases

    American Journal of Hematology, Vol. 27, Núm. 3, pp. 163-168

1987

  1. Análisis de factores pronósticos y modelos predictivos de respuesta a la quimioterapia de inducción en la leucemia aguda no linfoblástica.

    Medicina Clinica, Vol. 89, Núm. 4, pp. 135-140

  2. DESARROLLO Y VALIDACION DE MODELOS PREDICTIVOS DE RESPUESTA A LA QUIMIOTERAPIA DE INDUCCION INTENSIVA EN LA LEUCEMIA AGUDA NO LINFOBLASTICA

    Sangre, Vol. 32, Núm. 5, pp. 463-469

1986

  1. PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES

    The Lancet

  2. Valor pronóstico de la clasificación FAB en la LANL.

    Sangre

1985

  1. Experiencia con el uso del catéter de Hickman para el acceso venoso de pacientes con leucemia mieloblástica aguda.

    Sangre, Vol. 30, Núm. 5, pp. 889-898